论文部分内容阅读
该文测定了９７ 例恶性肿瘤患者红细胞免疫功能及Ｔ 淋巴细胞亚群各项指标。结果表明恶性肿瘤患者红细胞Ｃ３ｂ花环率乳腺癌术后低于正常对照组（Ｐ＜０－０５），其它各组均显著低于正常对照组（ Ｐ＜ ０－０１） 。免疫复合物花环率高于正常对照组，差别无显著性（ Ｐ＞０－０５）。各组肿瘤患者Ｔ淋巴细胞总数均显著低于正常对照组（ Ｐ＜ ０－０１） ，ＴＳ 较正常对照组增高，差别无显著性（Ｐ＞ ０－０５），ＴＨ／ＴＳ 比值降低，比值的高低与红细胞Ｃ３ｂ 受体活性呈正相关。提示：恶性肿瘤患者的红细胞免疫功能变化将影响Ｔ淋巴细胞的免疫功能，并研究探讨了二者之间的关系。
This article measures the red blood cell immune function and T lymphocyte subsets in 97 patients with malignant tumors. The results showed that the rate of red blood cell C3b rosette in patients with malignant tumors was lower than that in the normal control group (P<0-05), and the other groups were significantly lower than the normal control group (P<0-01). The immune complex rosette rate was higher than the normal control group, the difference was not significant (P>0-05). The total number of T-lymphocytes in each group of tumor patients was significantly lower than the normal control group (P < 0-01), TS was higher than the normal control group, the difference was not significant (P> 0-05), TH / TS ratio decreased, the ratio of The level is positively correlated with the red cell C3b receptor activity. Tip: The changes in red blood cell immune function in patients with malignant tumors will affect the immune function of T lymphocytes, and study the relationship between the two.